Supreme Court Won't Hear Patent Dispute Over Cox-2 Inhibitors

Law360, New York (November 30, 2004, 12:00 AM EST) -- The U.S. Supreme Court has refused to hear the University of Rochester’s appeal in its patent dispute with makers of cox-2 inhibitor pain killers, ending a legal battle that has cost the school $10 million.

Without explanation, the high court denied the school's request for a review of lower court rulings that dismissed its patent infringement claims against Pfizer Inc. and Merck & Co. over the class of anti-inflammatory drugs.

"We are, of course, very disappointed in the Supreme Court's decision," University of Rochester President Thomas...
To view the full article, register now.